Metastatic non-small cell lung cancer (NSCLC) is a life-threatening condition that affects thousands of individuals worldwide. With limited treatment options available, the search for more effective therapies has been an ongoing endeavor for researchers and healthcare professionals. One such hopeful advance is Osicent 80mg, a new medication that has shown promising results in clinical trials....